Table 2.
Risk factors for 90-d mortality in patients with hepatitis B virus-related acute-on-chronic liver failure
| Baseline variable | OR | Univariate 95%CI | P-value | OR | Multivariate 95%CI | P-value |
| Age (yr) | 0.850 | 0.701–1.051 | 0.642 | |||
| Gender | 0.519 | 0.096–2.741 | 0.422 | |||
| ALB (g/L) | 0.722 | 0.567–1.052 | 0.102 | |||
| PCT (ng/mL) | 1.003 | 0.999–1.006 | 0.152 | |||
| IL-6 (pg/mL) | 1.022 | 1.005–1.038 | 0.187 | |||
| MELD | 1.422 | 1.038–2.693 | 0.001 | 1.132 | 1.046-1.396 | 0.001 |
| sMR (pg/mL) | 1.062 | 1.005–1.038 | 0.001 | 1.007 | 1.004-1.012 | 0.001 |
HBV: Hepatitis B virus; ACLF: Acute-on-chronic liver failure. OR: Odds ratio; CI: Confidence interval; ALB: Albumin; PCT: Procalcitonin; IL-6: Interleukin-6; MELD: Model for end-stage liver disease; sMR: Soluble mannose receptor.